Cinctive Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Cinctive Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54,071	Closed	-$2.14M	–	554
2024 Q1	$2.14M	Buy	+54,071	New	+$1.6M	0.1%	209

Cinctive Capital Management's ALPN Position: Q2 2024 in Review

Cinctive Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 54,071 shares — an estimated $2.14M sold.

Cinctive Capital Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $2.14M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Cinctive Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Cinctive Capital Management sold 54,071 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.14M.
Cinctive Capital Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Cinctive Capital Management's Alpine Immune Sciences Inc position peaked at $2.14M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Cinctive Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.